# Olympus exercises option to acquire Medi-Tate

Olympus Corporation announced it has exercised its call option to acquire the remainder of shares in Medi-Tate Ltd., an Israeli medical device company specializing in minimally invasive treatment for benign prostatic hyperplasia. The acquisition aims to expand Olympus' urology business.

- Type: Acquisition
- Announced: 2021-02-26
- Where: Israel
- Status: announced
- Products: iTind device for BPH treatment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Olympus](https://endata.com/companies/30528.md) (acquirer)
- [Medi-Tate](https://endata.com/companies/35296.md) (target)

## Sources

- [olympusamerica.com](https://www.olympusamerica.com/press-release/2021-02-26/olympus-exercises-option-buy-israeli-medical-device-company-medi-tate), 2021-02-26: "the investment in Medi-Tate has expanded our patient care offerings in BPH, adding to Olympus’ market-leading plasma resection portfolio for transurethral resection of the prostate (TURP)."
- [mpo-mag.com](https://www.mpo-mag.com/breaking-news/olympus-purchases-israeli-firm-medi-tate-to-grow-urology-biz/), 2021-03-02: "The investment in Medi-Tate has expanded our patient care offerings in BPH, adding to Olympus’ market-leading plasma resection portfolio for transurethral resection of the prostate (TURP)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.